Skip to main content
AmigoFish

Episode 259 - Hannah Shen Founder & CEO - Kekulai

From The BioHub - by Avetix · · 28 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

In this episode of the BioHub podcast, Amber Hayes is joined by Hannah Shen, Founder and CEO of Kekulai, an end-to-end agentic drug discovery company focused on developing first-in-class medicines.

Drawing on her experience at Benchling and BridgeBio, Hannah shares her journey into biotech and the vision behind Kekulai's agentic discovery platform, Alchemy.

Together, they explore the challenges of building reliable AI agents for high-stakes scientific decisions, balancing human expertise with autonomous workflows, and why more data doesn't always mean better drug discovery.

Hannah also discusses how Kekulai is running three drug

A fascinating conversation about the future of agentic AI, scientific reasoning and what it takes to turn emerging technology into real medicines.

Back to The BioHub - by Avetix · Report a problem